OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
Plasma-based proteins and cell-based therapies have significant potential to address unmet medical needs.
Connected, integrated bioprocessing enterprises with greater data analytics capabilities are coming.
Clear understanding of what exactly the biomolecule entails is essential.